42 results
8-K
AUPH
Aurinia Pharmaceuticals Inc
29 Feb 24
Departure of Directors or Certain Officers
4:10pm
relationship with Dr. Volker Knappertz. Aurinia anticipates that it will provide Dr. Knappertz with a severance package substantially as set out in his
PX14A6G
z0p0nt zdiaazk2y
26 Apr 23
Letter to shareholders
10:20am
DEF 14A
t285z ikah
10 May 21
Definitive proxy
4:06pm
PRE 14A
xvg8 ei5bj3
27 Apr 21
Preliminary proxy
4:32pm
8-K
EX-99.2
xpdh 0tc12ohr20
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
8-K
EX-99.3
2sohqd2u 9g
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
8-K
EX-99.4
cwyx4tt65
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
10-K
npiwikk5
24 Feb 21
Annual report
4:09pm
8-K
EX-99.2
y3x81h75mvlrj w3m
25 Jan 21
Financial Statements and Exhibits
8:21am